Lisdexamfetamine

In the US, Lisdexamfetamine (lisdexamfetamine systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Asperger Syndrome, Chronic Fatigue Syndrome, Narcolepsy and Oppositional Defiant Disorder.

US matches:

• Lisdexamfetamine


• Lisdexamfetamine dimesylate

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0608137-32-2

Chemical Formula

C15-H25-N3-O

Molecular Weight

263

Therapeutic Category

Central stimulant

Chemical Names

(2S)-2,6-diamino-N-[(1S)-1-phenylpropan-2-yl]hexanamide (WHO)

(S)-2,6-Diaminhexansäure ((S)-1-methyl-2-phenylethyl)amid (IUPAC)

Foreign Names

• Lisdexamfetaminum (Latin)
• Lisdexamfetamin (German)
• Lisdexamfetamine (French)
• Lisdexamfetamina (Spanish)

Generic Names

• NRP-104 (IS)
• Lisdexamfetamine Dimesylate (OS: USAN)
• amfetamine prodrug (IS)
• LDX (IS)
• lis-dexamfetamine dimesylate (IS)
• L-lysine-d-amfetamine (IS)
• NRP 104 (IS: NewRiverPharma)

Brand Name

• Vyvanse
  Shire, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.